(Q33706393)

28 July 2017

title

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia (English)

1 reference

28 July 2017

1 reference

myelodysplastic syndrome

1 reference

1 reference

acute myeloid leukemia

1 reference

10

Robert Peter Gale

1 reference

28 July 2017

21

Martin S Tallman

1 reference

28 July 2017

12

Hillard M Lazarus

1 reference

28 July 2017

13

Selina Luger

1 reference

28 July 2017

1

Mark R Litzow

1 reference

28 July 2017

16

Philip L McCarthy

1 reference

28 July 2017

22

Daniel J Weisdorf

1 reference

28 July 2017

4

Brian J Bolwell

1 reference

28 July 2017

5

Mitchell S Cairo

1 reference

28 July 2017

15

Richard T Maziarz

1 reference

28 July 2017

3

Waleska S Pérez

1 reference

28 July 2017

6

Bruce M Camitta

1 reference

28 July 2017

7

Corey S Cutler

1 reference

28 July 2017

17

Marcelo C Pasquini

1 reference

28 July 2017

9

John F Dipersio

1 reference

28 July 2017

11

Armand Keating

1 reference

28 July 2017

19

J Douglas Rizzo

1 reference

28 July 2017

Sergey Tarima

2

1 reference

28 July 2017

Marcos de Lima

8

1 reference

28 July 2017

David I Marks

14

1 reference

28 July 2017

Gordon L Phillips

18

1 reference

28 July 2017

Jorge Sierra

20

1 reference

28 July 2017

language of work or name

English

0 references

publication date

23 December 2009

1 reference

28 July 2017

1 reference

28 July 2017

volume

115

1 reference

28 July 2017

issue

9

1 reference

28 July 2017

page(s)

1850-1857

1 reference

Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

International scoring system for evaluating prognosis in myelodysplastic syndromes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

1994 Consensus Conference on Acute GVHD Grading

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Evaluation of continuous infusion low-dose 5-azacytidine in the treatment of myelodysplastic syndromes

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Allogeneic Bone Marrow Transplantation for Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Long-Term Study of 70 Patients—Report of the French Society of Bone Marrow Transplantation

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2832815

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

30 October 2018

1 reference

12 December 2020

1 reference

12 December 2020

A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome

1 reference

12 December 2020

Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation

1 reference

12 December 2020

Prognostic variables in bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey of the working party on leukaemia

1 reference

12 December 2020

Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy

1 reference

12 December 2020

Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia

1 reference

12 December 2020

10.1182/BLOOD-2009-10-249128

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference